130 related articles for article (PubMed ID: 12412826)
1. Pharmacokinetics and pharmacodynamics of a new formulation of recombinant human growth hormone administered by ZomaJet 2 Vision, a new needle-free device, compared to subcutaneous administration using a conventional syringe.
Agersø H; Møller-Pedersen J; Cappi S; Thomann P; Jesussek B; Senderovitz T
J Clin Pharmacol; 2002 Nov; 42(11):1262-8. PubMed ID: 12412826
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of recombinant human growth hormone administered by cool.click 2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle.
Brearley C; Priestley A; Leighton-Scott J; Christen M
BMC Clin Pharmacol; 2007 Oct; 7():10. PubMed ID: 17922895
[TBL] [Abstract][Full Text] [Related]
3. Relative Bioavailability of a Single 4-mg Dose of Somatropin Administered by Subcutaneous Injection or by Needle-free Device and Coadministered With the Growth Hormone Inhibitor Octreotide Acetate in Healthy Adult Subjects.
Brimhall DB; Petri N; D'Angelo P
Clin Ther; 2018 May; 40(5):741-751. PubMed ID: 29699852
[TBL] [Abstract][Full Text] [Related]
4. Are needle-free injections a useful alternative for growth hormone therapy in children? Safety and pharmacokinetics of growth hormone delivered by a new needle-free injection device compared to a fine gauge needle.
Dörr HG; Zabransky S; Keller E; Otten BJ; Partsch CJ; Nyman L; Gillespie BK; Lester NR; Wilson AM; Hyrén C; van Kuijck MA; Schuld P; Schoenfeld SL
J Pediatr Endocrinol Metab; 2003 Mar; 16(3):383-92. PubMed ID: 12705363
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence studies of omnitrope, the first biosimilar/rhGH follow-on protein: two comparative phase 1 randomized studies and population pharmacokinetic analysis.
Stanhope R; Sörgel F; Gravel P; Pannatier Schuetz YB; Zabransky M; Muenzberg M
J Clin Pharmacol; 2010 Nov; 50(11):1339-48. PubMed ID: 20173088
[TBL] [Abstract][Full Text] [Related]
6. Intranasal Human Growth Hormone (hGH) Induces IGF-1 Levels Comparable With Subcutaneous Injection With Lower Systemic Exposure to hGH in Healthy Volunteers.
Lewis AL; Jordan F; Patel T; Jeffery K; King G; Savage M; Shalet S; Illum L
J Clin Endocrinol Metab; 2015 Nov; 100(11):4364-71. PubMed ID: 26425883
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic bioequivalence of enfuvirtide using a needle-free device versus standard needle administration.
True AL; Chiu YY; Demasi RA; Stout R; Patel I
Pharmacotherapy; 2006 Dec; 26(12):1679-86. PubMed ID: 17125431
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects.
Flouvat B; Leneveu A; Fitoussi S; Delhotal-Landes B; Gendron A
Int J Clin Pharmacol Ther; 2004 Jan; 42(1):50-7. PubMed ID: 14756388
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetic and pharmacodynamic evaluation between a new biosimilar and reference recombinant human growth hormone.
Toffoletto O; Afiune J; Thiemann JE; Khandave SS; Patel S; Rodrigues DG
Growth Horm IGF Res; 2016; 30-31():31-36. PubMed ID: 27657985
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence of subcutaneous injections of recombinant human follicle stimulating hormone (Puregon(R)) by Pen-injector and syringe.
Voortman G; van de Post J; Schoemaker RC; van Gerven JM
Hum Reprod; 1999 Jul; 14(7):1698-702. PubMed ID: 10402370
[TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children.
Hou L; Chen ZH; Liu D; Cheng YG; Luo XP
Drug Des Devel Ther; 2016; 10():13-21. PubMed ID: 26719670
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous administration of midazolam: a comparison of the Bioject jet injector with the conventional syringe and needle.
Bennett J; Nichols F; Rosenblum M; Condry J
J Oral Maxillofac Surg; 1998 Nov; 56(11):1249-54. PubMed ID: 9820211
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of recombinant human growth hormone by subcutaneous jet- or needle-injection in patients with growth hormone deficiency.
Houdijk EC; Herdes E; Delemarre-Van de Waal HA
Acta Paediatr; 1997 Dec; 86(12):1301-7. PubMed ID: 9475305
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of a single dose of recombinant human growth hormone after subcutaneous administration by jet-injection: comparison with conventional needle-injection.
Verhagen A; Ebels JT; Dogterom AA; Jonkman JH
Eur J Clin Pharmacol; 1995; 49(1-2):69-72. PubMed ID: 8751024
[TBL] [Abstract][Full Text] [Related]
15. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers.
Cho HY; Yoon H; Park GK; Lee YB
Clin Ther; 2009 Nov; 31(11):2712-21. PubMed ID: 20110013
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
[TBL] [Abstract][Full Text] [Related]
19. A pharmacokinetic/pharmacodynamic model for recombinant human growth hormone effects on induction of insulin-like growth factor I in monkeys.
Sun YN; Lee HJ; Almon RR; Jusko WJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1523-32. PubMed ID: 10336548
[TBL] [Abstract][Full Text] [Related]
20. Bioequivalence between ready-to-use recombinant human growth hormone (rhGH) in liquid formulation and rhGH for reconstitution.
Jacobsen LV; Rolan P; Christensen MS; Knudsen KM; Rasmussen MH
Growth Horm IGF Res; 2000 Apr; 10(2):93-8. PubMed ID: 10931747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
